Distinction between atypical lymphoid proliferations with follicular pattern and follicular ... significant lymphadenopathy – that is, lymph nodes >2 cm in size – organomegaly (hepatomegaly ...

Most follicular lymphoma cases exhibit classic clinicopathologic ... need to be differentiated from atypical lymphoid hyperplasia of the lymph nodes and tonsils. 5 FL variants with predominantly ...

What’s the next step for this patient with a 4-year history of low-grade follicular lymphoma and who ... for bilateral enlarged cervical lymph nodes, largest 4 x 5 cm, and bilateral inguinal ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas, and due to innovations in manufacturing, could ...

Axicabtagene ciloleucel had durable responses, long-term survival, and consistent outcomes in patients with relapsed or ...

There is currently no standard first-line chemotherapy regimen for the treatment of patients with follicular lymphoma. A recent study by Gilles Salles et al. has shown that the combination of ...

At the 2024 American Society of Hematology (ASH) Annual Meeting & Exposition last month, the company announced positive ...

Tafasitamab increased progression free survival by about 9 months when compared to placebo, according to recent study data.

A panelist discusses how various antibody-drug conjugates, including polatuzumab vedotin, pinatuzumab vedotin, and ...

Liso-cel, a CD19-directed chimeric antigen receptor T-cell product, and mosunetuzumab, a CD20/CD3 bispecific antibody, are used to treat patients with relapsed/refractory follicular lymphoma.

Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in ...

Dr. Sattva S. Neelapu discusses how the CAR-T therapy Yescarta impacts the quality of life of patients with R/R indolent non-Hodgkin lymphoma.